Published ahead of print on May 30, 2003, doi:10.1165/rcmb.2002-0315OC
Am. J. Respir. Cell Mol. Biol., Volume 29, Number 5, November 2003, 583-590
A more recent version of this article appeared on November 1, 2003
Submitted on December 27, 2002
Revised on May 28, 2003
Involvement of SRF Isoforms in Myofibroblast Differentiation During Bleomycin-Induced Lung Injury
Yan Yang1, Xiaoning Zhe2, Sem H Phan3, Matt Ullenbruch3, and Lucia Schuger2*
1 Pathology, Wayne State University School of Medicine, Detroit, MI, USA; Human Genome Sciences, Inc., Rockville, MD, USA,
2 Pathology, Wayne State University School of Medicine, Detroit, MI, USA,
3 Pathology, University of Michigan Medical School, Ann Arbor, MI, USA
* To whom correspondence should be addressed. E-mail: lschuger{at}med.wayne.edu.
Serum response factor (SRF) is a transcription factor essential for smooth muscle (SM) myogenesis. Its role in myofibroblast differentiation is however unknown. Here we studied the expression and the localization of SRF in bleomycin-induced pulmonary fibrosis, where myofibroblasts are abundant. We found that SRF levels were upregulated in bleomycin-exposed mouse lungs mainly due to de novo synthesis of SRF 5, a less myogenic SRF isoform. Prior to myofibroblast differentiation, SRF/SRF 5 was immunolocalized mostly in the cytoplasm of scattered fibroblasts at lesion sites. With the development of myofibroblasts, however, SRF/SRF 5 was found in myofibroblast nuclei. cDNA array analysis showed that SRF 5 and SRF induced expression of TGF- 1, a critical factor in myofibroblast differentiation. This was accompanied by de novo expression of several inflammatory cell-specific mRNAs. The latter was confirmed by RT-PCR. Treatment of lung fibroblasts with TNF- , which is produced early in the bleomycin model, induced SRF 5 expression and SRF/SRF 5 cytoplasmic accumulation, whereas addition of TGF- 1 caused SRF/SRF 5 nuclear translocation followed by SM -actin synthesis. IL-4, another cytokine involved in myofibroblast differentiation did not affect SRF or induce SRF 5 expression. Our studies therefore suggested a new mechanism thereby SRF and SRF 5 contribute to the emergence of myofibroblasts in lung injury and fibrosis.
This article has been cited by other articles:

|
 |

|
 |
 
J. Chai, M. Norng, A. S Tarnawski, and J. Chow
A critical role of serum response factor in myofibroblast differentiation during experimental oesophageal ulcer healing in rats
Gut,
May 1, 2007;
56(5):
621 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rene, M. Taulan, F. Iral, J. Doudement, A. L'Honore, C. Gerbon, J. Demaille, M. Claustres, and M.-C. Romey
Binding of serum response factor to cystic fibrosis transmembrane conductance regulator CArG-like elements, as a new potential CFTR transcriptional regulation pathway
Nucleic Acids Res.,
September 16, 2005;
33(16):
5271 - 5290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-F. Ma, D. N. Grigoryev, A. D. Taylor, S. Nonas, S. Sammani, S. Q. Ye, and J. G. N. Garcia
Bioinformatic identification of novel early stress response genes in rodent models of lung injury
Am J Physiol Lung Cell Mol Physiol,
September 1, 2005;
289(3):
L468 - L477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Tomasek, J. McRae, G. K. Owens, and C. J. Haaksma
Regulation of {alpha}-Smooth Muscle Actin Expression in Granulation Tissue Myofibroblasts Is Dependent on the Intronic CArG Element and the Transforming Growth Factor-{beta}1 Control Element
Am. J. Pathol.,
May 1, 2005;
166(5):
1343 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Lawson, V. V. Polosukhin, O. Zoia, G. T. Stathopoulos, W. Han, D. Plieth, J. E. Loyd, E. G. Neilson, and T. S. Blackwell
Characterization of Fibroblast-specific Protein 1 in Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
April 15, 2005;
171(8):
899 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|